Lupo, Philip J, Chambers, Tiffany M, Mueller, Beth A, Clavel, Jacqueline, Dockerty, John D, Doody, David R, Erdmann, Friederike, Ezzat, Sameera, Filippini, Tommaso, Hansen, Johnni, Heck, Julia E, Infante‐Rivard, Claire, Kang, Alice Y, Magnani, Corrado, Malagoli, Carlotta, Marcotte, Erin L, Metayer, Catherine, Bailey, Helen D, Mora, Ana M, Ntzani, Evangelia, Petridou, Eleni Th, Pombo‐de‐Oliveira, Maria S, Rashed, Wafaa M, Roman, Eve, Schüz, Joachim, Wesseling, Catharina, Spector, Logan G, and Scheurer, Michael E
Although recent studies have demonstrated associations between nonchromosomal birth defects and several pediatric cancers, less is known about their role on childhood leukemia susceptibility. Using data from the Childhood Cancer and Leukemia International Consortium, we evaluated associations between nonchromosomal birth defects and childhood leukemia. Pooling consortium data from 18 questionnaire-based and three registry-based case-control studies across 13 countries, we used multivariable logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between a spectrum of birth defects and leukemia. Our analyses included acute lymphoblastic leukemia (ALL, n = 13 115) and acute myeloid leukemia (AML, n = 2120) cases, along with 46 172 controls. We used the false discovery rate to account for multiple comparisons. In the questionnaire-based studies, the prevalence of birth defects was 5% among cases vs 4% in controls, whereas, in the registry-based studies, the prevalence was 11% among cases vs 7% in controls. In pooled adjusted analyses, there were several notable associations, including (1) digestive system defects and ALL (OR = 2.70, 95% CI: 1.46-4.98); (2) congenital anomalies of the heart and circulatory system and AML (OR = 2.86, 95% CI: 1.81-4.52) and (3) nervous system defects and AML (OR = 4.23, 95% CI: 1.50-11.89). Effect sizes were generally larger in registry-based studies. Overall, our results could point to novel genetic and environmental factors associated with birth defects that could also increase leukemia susceptibility. Additionally, differences between questionnaire- and registry-based studies point to the importance of complementary sources of birth defect phenotype data when exploring these associations.